Suven Pharmaceuticals share price
You have to be logged in to add this to Watchlist.Suven Pharmaceuticals is trading -1.49% lower at Rs 1,275.05 as compared to its last closing price. Suven Pharmaceuticals has been trading in the price range of 1,333.65 & 1,270.80. Suven Pharmaceuticals has given 79.19% in this year & 2.60% in the last 5 days.
Suven Pharmaceuticals has TTM P/E ratio 122.75 as compared to the sector P/E of 33.29.There are 1 analysts who have initiated coverage on Suven Pharmaceuticals. There are 1 analysts who have given it a strong buy rating & 0 analysts have given it a buy rating. 0 analysts have given the stock a sell rating.
The company posted a net profit of 82.21 Crores in its last quarter.
Listed peers of Suven Pharmaceuticals include Ajanta Pharmaceuticals (1.40%), Syngene International (2.97%), Suven Pharmaceuticals (-1.49%) etc.
Suven Pharmaceuticals has a 49.90% public holding.The Mutual Fund holding in Suven Pharmaceuticals was at 14.12% in 30 Sep 2024. The MF holding has decreased from the last quarter. The FII holding in Suven Pharmaceuticals was at 10.70% in 30 Sep 2024. The FII holding has decreased from the last quarter.
Suven Pharmaceuticals share price range
|
| ||||
|
| ||||
Suven Pharmaceuticals share Key Metrics
| Market Cap ( ₹ Cr.) | 32,969.98 | ||||||||||||||||||
|
|
Technical Trends
Long TermConsiders price movement over the last 6 months
Short TermConsiders price movement over the last 1-2 weeks
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Suven Pharmaceuticals Corporate actions
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
| 12-Nov-24 | Quarterly Results |
| 09-Aug-24 | Quarterly Results |
| 30-May-24 | Audited Results |
| 05-Feb-24 | Quarterly Results |
| 09-Nov-23 | Quarterly Results |
| 08-Aug-23 | Quarterly Results |
| 25-May-23 | Audited Results |
| 06-Feb-23 | Quarterly Results |
| 08-Nov-22 | Quarterly Results |
| 08-Aug-22 | Quarterly Results |
| Meeting Date | Announcement On | Purpose |
| 09-Aug-24 | 15-Jul-24 | AGM |
| 15-Feb-24 | 12-Jan-24 | POM |
| 15-Dec-23 | 10-Nov-23 | AGM |
| 14-Dec-23 | 13-Nov-23 | POM |
| 18-Aug-22 | 09-May-22 | AGM |
| 31-Aug-21 | 08-Jun-21 | AGM |
| Announcement On | Record Date | Ex-Dividend | Dividend Value |
| 29-Aug-22 | 12-Sep-22 | 09-Sep-22 | 1 |
| 30-Aug-22 | 12-Sep-22 | 09-Sep-22 | 5 |
| 02-May-22 | 17-May-22 | 13-May-22 | 1 |
| 03-May-22 | 17-May-22 | 13-May-22 | 1 |
| 01-Feb-22 | 16-Feb-22 | 15-Feb-22 | 1 |
| 02-Feb-22 | 16-Feb-22 | 15-Feb-22 | 2 |
| 08-Jun-21 | 17-Aug-21 | 13-Aug-21 | 1 |
| 03-Feb-21 | 18-Feb-21 | 17-Feb-21 | 1 |
FAQs about Suven Pharmaceuticals share price
Suven Pharmaceuticals is trading at 1275.05 as on Mon Nov 25 2024 09:59:44. This is -1.49% lower as compared to its previous closing price of 1294.35.
The market capitalization of Suven Pharmaceuticals is 32969.98 Cr as on Mon Nov 25 2024 09:59:44.
The average broker rating on Suven Pharmaceuticals is Strong Buy. The breakup of analyst rating is given below -
- 1 analysts have given a strong buy rating
- 0 analysts have given a buy rating
- 0 analysts have given a hold rating
- 0 analysts have given a sell rating
- 0 analysts have given a strong sell rating
The 52 wk high for Suven Pharmaceuticals is 1358.75 whereas the 52 wk low is 578.05
Suven Pharmaceuticals can be analyzed on the following key metrics -
- TTM P/E: 122.75
- Sector P/E: 33.29
- Dividend Yield: 0.00%
- D/E ratio: 0.02
Suven Pharmaceuticals reported a net profit of 300.28 Cr in 2024.
Suven Pharmaceuticals Quick Links
Suven Pharmaceuticals Dividend Suven Pharmaceuticals Bonus Suven Pharmaceuticals News Suven Pharmaceuticals AGM Suven Pharmaceuticals Rights Suven Pharmaceuticals Splits Suven Pharmaceuticals Board Meetings Suven Pharmaceuticals Key Metrics Suven Pharmaceuticals Shareholdings Suven Pharmaceuticals Profit Loss Suven Pharmaceuticals Balance Sheet Suven Pharmaceuticals Cashflow Suven Pharmaceuticals Q1 Results Suven Pharmaceuticals Q2 Results Suven Pharmaceuticals Q3 Results Suven Pharmaceuticals Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks